What should I know first?

Bupropion is an antidepressant whose pharmacology differs from serotonin reuptake inhibitors. This lesson uses Wellbutrin XL, an extended-release bupropion hydrochloride tablet.

The U.S. Wellbutrin XL label covers major depressive disorder and prevention of seasonal major depressive episodes in people with seasonal affective disorder. This is not the smoking-cessation product label. Different formulations and uses require separate information.

This is a mechanism lesson, not a complete medicine guide. A diagram cannot choose treatment, predict your response, or tell you how to change a prescription.

How Brain Cells Communicate

Norepinephrine and dopamine are chemical messengers with their own transport systems. Returning a messenger into a nerve cell is called reuptake. This process is one part of signaling, not a direct measure of mood.

Dopamine · DAT

A transporter across a membrane, with the sending-cell interior above and released messenger outside below. The uptake direction is upward. Dopamine: The messenger is shown outside the sending cell. DAT: The DAT transporter returns dopamine into the cell. Return into the cell: The arrow shows transport direction, without a measured rate.
  1. Dopamine

    The messenger is shown outside the sending cell.

  2. DAT

    The DAT transporter returns dopamine into the cell.

  3. Return into the cell

    The arrow shows transport direction, without a measured rate.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Norepinephrine · NET

A transporter across a membrane, with the sending-cell interior above and released messenger outside below. The uptake direction is upward. Norepinephrine: The messenger is shown outside the sending cell. NET: The NET transporter returns norepinephrine into the cell. Return into the cell: The arrow shows transport direction, without a measured rate.
  1. Norepinephrine

    The messenger is shown outside the sending cell.

  2. NET

    The NET transporter returns norepinephrine into the cell.

  3. Return into the cell

    The arrow shows transport direction, without a measured rate.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Qualitative uptake model; it is not an SSRI diagram with a different name, a complete metabolite model, or a prediction of response.
About this illustration

Norepinephrine and dopamine transporters return the respective messengers into cells. Each transporter is distinct.

How the Medication Changes Signaling

The product label describes bupropion as a relatively weak inhibitor of neuronal norepinephrine and dopamine uptake. It does not describe serotonin reuptake inhibition as its action.

The teaching symbol is qualitative. A weaker effect in an experimental measure cannot by itself establish weaker clinical benefit, or tell you how medicines compare for an individual.

Explore the mechanism

How does this example differ from serotonin reuptake inhibition?

Dopamine · DAT

A transporter across a membrane, with the sending-cell interior above and released messenger outside below. The uptake direction is upward. Dopamine: The messenger is shown outside the sending cell. DAT: The DAT transporter returns dopamine into the cell. Return into the cell: The arrow shows transport direction, without a measured rate.
  1. Dopamine

    The messenger is shown outside the sending cell.

  2. DAT

    The DAT transporter returns dopamine into the cell.

  3. Return into the cell

    The arrow shows transport direction, without a measured rate.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Norepinephrine · NET

A transporter across a membrane, with the sending-cell interior above and released messenger outside below. The uptake direction is upward. Norepinephrine: The messenger is shown outside the sending cell. NET: The NET transporter returns norepinephrine into the cell. Return into the cell: The arrow shows transport direction, without a measured rate.
  1. Norepinephrine

    The messenger is shown outside the sending cell.

  2. NET

    The NET transporter returns norepinephrine into the cell.

  3. Return into the cell

    The arrow shows transport direction, without a measured rate.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Static introduction. Qualitative uptake model; it is not an SSRI diagram with a different name, a complete metabolite model, or a prediction of response.

Dopamine · DAT

A transporter across a membrane, with the sending-cell interior above and released messenger outside below. The uptake direction is upward. Dopamine: The messenger is shown outside the sending cell. DAT: The DAT transporter returns dopamine into the cell. Return into the cell: The arrow shows transport direction, without a measured rate.
  1. Dopamine

    The messenger is shown outside the sending cell.

  2. DAT

    The DAT transporter returns dopamine into the cell.

  3. Return into the cell

    The arrow shows transport direction, without a measured rate.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Norepinephrine · NET

A transporter across a membrane, with the sending-cell interior above and released messenger outside below. The uptake direction is upward. Norepinephrine: The messenger is shown outside the sending cell. NET: The NET transporter returns norepinephrine into the cell. Return into the cell: The arrow shows transport direction, without a measured rate.
  1. Norepinephrine

    The messenger is shown outside the sending cell.

  2. NET

    The NET transporter returns norepinephrine into the cell.

  3. Return into the cell

    The arrow shows transport direction, without a measured rate.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Before medicine: uptakeNorepinephrine and dopamine transporters return the respective messengers into cells. Each transporter is distinct.

Dopamine · DAT

A membrane transporter with uptake reduced; messenger remains outside below the membrane. The separate terracotta symbol denotes a medicine, not its molecular shape. Dopamine: The messenger is shown outside the sending cell. DAT: The DAT transporter returns dopamine into the cell. Bupropion: uptake inhibited: The interrupted arrow names the action; the symbol is not a molecular shape or binding position.
  1. Dopamine

    The messenger is shown outside the sending cell.

  2. DAT

    The DAT transporter returns dopamine into the cell.

  3. Bupropion: uptake inhibited

    The interrupted arrow names the action; the symbol is not a molecular shape or binding position.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Norepinephrine · NET

A membrane transporter with uptake reduced; messenger remains outside below the membrane. The separate terracotta symbol denotes a medicine, not its molecular shape. Norepinephrine: The messenger is shown outside the sending cell. NET: The NET transporter returns norepinephrine into the cell. Bupropion: uptake inhibited: The interrupted arrow names the action; the symbol is not a molecular shape or binding position.
  1. Norepinephrine

    The messenger is shown outside the sending cell.

  2. NET

    The NET transporter returns norepinephrine into the cell.

  3. Bupropion: uptake inhibited

    The interrupted arrow names the action; the symbol is not a molecular shape or binding position.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

With bupropionBupropion has relatively weak inhibitory effects on norepinephrine and dopamine uptake in the product pharmacology. The symbol is not a strength scale.

What this model cannot tell us

Clinical mechanism unknown

  • Clinical mechanism unknown The clinical explanation remains uncertain.
  • Limits of inference An experimental result does not by itself predict one person’s treatment response.
What remains uncertainThe exact antidepressant mechanism remains unknown. This does not establish a simple messenger deficiency or rank medicines.

Static overview. Start the steps when you are ready.

Guide to the illustration: Outlines identify a cell membrane or target; arrows mark the direction explained in each caption. Medicine symbols are labels, not measured shapes or binding poses. No quantity, size or rate is to scale.

Read the complete sequence
  1. Before medicine: uptake. Norepinephrine and dopamine transporters return the respective messengers into cells. Each transporter is distinct.
  2. With bupropion. Bupropion has relatively weak inhibitory effects on norepinephrine and dopamine uptake in the product pharmacology. The symbol is not a strength scale.
  3. What remains uncertain. The exact antidepressant mechanism remains unknown. This does not establish a simple messenger deficiency or rank medicines.
Evidence and model limits

Wellbutrin XL labeling distinguishes uptake effects from the unknown antidepressant mechanism. No cross-assay potency ranking is inferred.

Qualitative uptake model; it is not an SSRI diagram with a different name, a complete metabolite model, or a prediction of response.

A Closer Look at the Molecular Level

Known action: effects on norepinephrine and dopamine uptake are described in the pharmacology. Active metabolites also exist, so the parent medicine alone does not describe every aspect of exposure.

Clinical uncertainty: the precise antidepressant mechanism is unknown. This is not a diagram showing that depression is caused by low dopamine or norepinephrine. It gives no dose, transporter occupancy or complete prediction of effects.

Sources and References

The sources below support the specific medicine and experimental context described here. Drawings are original qualitative teaching models; positions, arrows and timing do not give atomic geometry, occupancy or rates.

  1. DailyMed: Wellbutrin XL, updated February2026
  2. NIH: What Is a Neurotransmitter?
  3. FDA: Wellbutrin XL prescribing information and Medication Guide

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top